Cargando…

Study on the daily dose and serum concentration of clozapine in psychiatric patients and possible influencing factors of serum concentration

BACKGROUND: Clozapine is the most effective drug for treatment-resistant schizophrenia, and the dosage and concentration of clozapine in the treatment of mental illness vary greatly in different populations and are affected by many factors. METHODS: The serum clozapine concentration of 3734 psychiat...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Taixiu, Gao, Peng, Xie, Chuange, Zhang, Heng, Shi, Zheng, Chen, Ruirui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428656/
https://www.ncbi.nlm.nih.gov/pubmed/37582705
http://dx.doi.org/10.1186/s12888-023-05078-z
_version_ 1785090522737541120
author Liu, Taixiu
Gao, Peng
Xie, Chuange
Zhang, Heng
Shi, Zheng
Chen, Ruirui
author_facet Liu, Taixiu
Gao, Peng
Xie, Chuange
Zhang, Heng
Shi, Zheng
Chen, Ruirui
author_sort Liu, Taixiu
collection PubMed
description BACKGROUND: Clozapine is the most effective drug for treatment-resistant schizophrenia, and the dosage and concentration of clozapine in the treatment of mental illness vary greatly in different populations and are affected by many factors. METHODS: The serum clozapine concentration of 3734 psychiatric patients was detected, and data on daily dose, sex, age and other medical records were collected for statistical analysis. RESULTS: The mean daily dose, mean serum concentration and mean C/D (concentration/dose) ratio of clozapine were 191.02 ± 113.47 mg/day, 326.15 ± 235.66 ng/mL and 1.94 ± 1.25 ng/mL per mg/day, respectively. There was difference in daily dose between sexes, and females had higher daily dose (p <0.01), higher serum clozapine concentrations (p < 0.01) and higher C/D ratios (p < 0.01). There were significant differences in daily dose (p < 0.001), serum drug concentration (p < 0.001) and C/D ratio (p < 0.001) among different age groups. The daily dose decreased with age (p for trend < 0.001), and the C/D ratio increased with age (p for trend < 0.001). Inpatients and outpatients had no difference in daily dose, but inpatients had higher serum concentration (p < 0.001) and C/D ratio (p < 0.001). There was no difference in daily dose among different occupations, but there were significant differences in serum concentration (p < 0.001) and C/D ratio (p < 0.001), and unemployed patients may have higher serum concentration and C/D ratio. Duration of disease, comorbidity, marital status, and psychotic type may influence the daily dose and serum concentration. CONCLUSIONS: The effective daily dose and serum concentration of clozapine in the study area may be lower than recommended levels, and women have higher serum concentrations and slower metabolic rates. With increasing age, the daily dose decreases, and the metabolic rate slows. Inpatient status and occupation of patients may influence the serum concentration and metabolic rate of clozapine.
format Online
Article
Text
id pubmed-10428656
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-104286562023-08-17 Study on the daily dose and serum concentration of clozapine in psychiatric patients and possible influencing factors of serum concentration Liu, Taixiu Gao, Peng Xie, Chuange Zhang, Heng Shi, Zheng Chen, Ruirui BMC Psychiatry Research Article BACKGROUND: Clozapine is the most effective drug for treatment-resistant schizophrenia, and the dosage and concentration of clozapine in the treatment of mental illness vary greatly in different populations and are affected by many factors. METHODS: The serum clozapine concentration of 3734 psychiatric patients was detected, and data on daily dose, sex, age and other medical records were collected for statistical analysis. RESULTS: The mean daily dose, mean serum concentration and mean C/D (concentration/dose) ratio of clozapine were 191.02 ± 113.47 mg/day, 326.15 ± 235.66 ng/mL and 1.94 ± 1.25 ng/mL per mg/day, respectively. There was difference in daily dose between sexes, and females had higher daily dose (p <0.01), higher serum clozapine concentrations (p < 0.01) and higher C/D ratios (p < 0.01). There were significant differences in daily dose (p < 0.001), serum drug concentration (p < 0.001) and C/D ratio (p < 0.001) among different age groups. The daily dose decreased with age (p for trend < 0.001), and the C/D ratio increased with age (p for trend < 0.001). Inpatients and outpatients had no difference in daily dose, but inpatients had higher serum concentration (p < 0.001) and C/D ratio (p < 0.001). There was no difference in daily dose among different occupations, but there were significant differences in serum concentration (p < 0.001) and C/D ratio (p < 0.001), and unemployed patients may have higher serum concentration and C/D ratio. Duration of disease, comorbidity, marital status, and psychotic type may influence the daily dose and serum concentration. CONCLUSIONS: The effective daily dose and serum concentration of clozapine in the study area may be lower than recommended levels, and women have higher serum concentrations and slower metabolic rates. With increasing age, the daily dose decreases, and the metabolic rate slows. Inpatient status and occupation of patients may influence the serum concentration and metabolic rate of clozapine. BioMed Central 2023-08-15 /pmc/articles/PMC10428656/ /pubmed/37582705 http://dx.doi.org/10.1186/s12888-023-05078-z Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Liu, Taixiu
Gao, Peng
Xie, Chuange
Zhang, Heng
Shi, Zheng
Chen, Ruirui
Study on the daily dose and serum concentration of clozapine in psychiatric patients and possible influencing factors of serum concentration
title Study on the daily dose and serum concentration of clozapine in psychiatric patients and possible influencing factors of serum concentration
title_full Study on the daily dose and serum concentration of clozapine in psychiatric patients and possible influencing factors of serum concentration
title_fullStr Study on the daily dose and serum concentration of clozapine in psychiatric patients and possible influencing factors of serum concentration
title_full_unstemmed Study on the daily dose and serum concentration of clozapine in psychiatric patients and possible influencing factors of serum concentration
title_short Study on the daily dose and serum concentration of clozapine in psychiatric patients and possible influencing factors of serum concentration
title_sort study on the daily dose and serum concentration of clozapine in psychiatric patients and possible influencing factors of serum concentration
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428656/
https://www.ncbi.nlm.nih.gov/pubmed/37582705
http://dx.doi.org/10.1186/s12888-023-05078-z
work_keys_str_mv AT liutaixiu studyonthedailydoseandserumconcentrationofclozapineinpsychiatricpatientsandpossibleinfluencingfactorsofserumconcentration
AT gaopeng studyonthedailydoseandserumconcentrationofclozapineinpsychiatricpatientsandpossibleinfluencingfactorsofserumconcentration
AT xiechuange studyonthedailydoseandserumconcentrationofclozapineinpsychiatricpatientsandpossibleinfluencingfactorsofserumconcentration
AT zhangheng studyonthedailydoseandserumconcentrationofclozapineinpsychiatricpatientsandpossibleinfluencingfactorsofserumconcentration
AT shizheng studyonthedailydoseandserumconcentrationofclozapineinpsychiatricpatientsandpossibleinfluencingfactorsofserumconcentration
AT chenruirui studyonthedailydoseandserumconcentrationofclozapineinpsychiatricpatientsandpossibleinfluencingfactorsofserumconcentration